Тема статьи

Авторы

Набиева Ф.С.

Учреждение

Бухарский государственный медицинский институт

Аннотация

В настоящее время не существует стандартных подходов к наблюдению за па-циентами с раком яичников (РЯ). Хотя роль ультразвукового исследования (УЗИ) четко опре-делена в первичной диагностике РЯ, она по-прежнему остается спорной во время наблюдения за пациентами с хирургическим лечением РЯ. При внедрении в качестве стандартной проце-дуры последующего наблюдения УЗИ может сыграть центральную роль в раннем выявлении рецидива рака яичников (РРЯ).

Ключевые слова

Рак яичников, рецидив рака яичников (РРЯ), УЗИ ;

Литературы

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67:7-30.
2. du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour Les Etudes Des Cancers De l'Ovaire (GINECO). Cancer 2009;115:1234-44.
3. Gueli Alletti S, Capozzi VA, Rosati A, et al. Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature. Minerva Med 2019;110:341-57.
4. Bentivegna E, Gouy S, Maulard A, et al. Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues. Ann Oncol 2016;27:1994-2004.
5. Fruscio R, Corso S, Ceppi L, et al. Conservative management of earlystage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol 2013;24:138-44.
6. Bentivegna E, Fruscio R, Roussin S, et al. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients. Fertil Steril 2015;104:1319-24.
7. Lheureux S, Braunstein M, Oza AM. Epithelial Ovarian Cancer: Evolution of Management in the Era of Precision Medicine. Ca Cancer J Clin 2019;69:280-304.
8. Trimbos JB, Parmar M, Vergote I, et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
9. Клиническая онкогинекология под редакцией Ф. Дж. Дисаи, У.Т. Крисмана 2012 том 3
10. Новикова Е.Г., Батталова Г.Ю. Пограничные опухоли яичников, 2007
11. Диагностика и лечение рака яичников. Под редакцией В.А. Горбуновой 2011
12. Практическая онкогинекология: избранные лекции. Под редакцией А.Ф. Урменчеевой, С.А. Тюляндина, В.М.Моисеенко 2006.
13. Boume T.H., Campbell S., Reynolds K.M., et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and color blood flow imaging.// Br. Med. J.–1993.–Vol. 306.–P. 1025.
14. De Priest P.D., Varner E., Powell J., et al. The efficacy of sonographic morphology index in identifying ovarian cancer: a multic institutional investigation.// Oncol.–1994.–Vol. 55.–P. 174
15. Kurjak A., Shalan H., Kupesic S., et al. An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography.// J. Ultrasound Med.–1994.–Vol.
16. Laganà AS, Colonese F, Colonese E, et al. Cytogenetic Analysis of Epithelial Ovarian Cancer's Stem Cells: An Overview on New Diagnostic and Therapeutic Perspectives. Eur J Gynaecol Oncol 2015;36:495-505.
17. Laganà AS, Sofo V, Vitale SG, et al. Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecol Oncol Rep 2016;18:57-8.
18. Testa AC, Ciampelli M, Mastromarino C, et al. Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy. Ultrasound Obstet Gynecol 2002;19:490-5.
19. Testa AC, Fruscella E, Ludovisi M, et al. The role of sonographic examination in the follow-up of gynecological neoplasms. Gynecol Oncol 2005;99:696-703.
20. Shen ZY, Shen AJ, Yang SL, et al. Combination of Sonographic Morphology Score and Tumor Markers for Detecting Postoperative Recurrent Pelvic Ovarian Carcinoma: Compared With MRI Assessment. Ultrasound Q 2019;35:45-53.
21. Sugiyama T, Nishida T, Komai K, et al. Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer. Int J Gynaecol Obstet 1996;54:251-6.
22. Fehm T, Heller F, Krämer S, et al. Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients. Anticancer Res 2005;25:1551-4.
23. Fischerova D, Cibula D, Dundr P, et al. Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors. Int J Gynecol Cancer 2008;18:833-7.
24. Zikan M, Fischerova D, Pinkavova I, et al. Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology. Ultrasound Obstet Gynecol 2010;36:767-72.
25. Mascilini F, Quagliozzi L, Moro F, et al. Role of transvaginal ultrasound-guided biopsy in gynecology. Int J Gynecol Cancer 2020;30:128-32.
26. Набиева Ф.С. Электронный научный журнал «Биология и интегративная медицина» 2016 №2 (май): 128-129